Clinical trial
How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
NCT03755570 is registered in ClinicalTrials.gov with Royal Cornwall Hospitals Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
- Lead sponsor
- Royal Cornwall Hospitals Trust
- Phase
- Observational
- Overall status
- Suspended
- Start date
- June 21, 2019
- Completion date
- January 14, 2024
- Enrollment
- 198 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cognitive change, cognitive impairment, cognitive impairment, mild, heart failure, heart failure, systolic, left ventricular dysfunction, left ventricular systolic dysfunction, systolic dysfunction, systolic heart failure